Trial Profile
An Open Label Evaluation of the Safety and Efficacy of Basiliximab Maintenance in Ulcerative Colitis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 24 Sep 2019
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary) ; Prednisolone
- Indications Ulcerative colitis
- Focus Adverse reactions
- Sponsors Cerimon Pharmaceuticals
- 09 Jun 2011 New trial record